
Lapatinib Tablets
| Product/Composition | Lapatinib Tablets |
|---|---|
| Form | Tablet |
| Strength | 250mg |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Lapatinib Tablets are a prescription medicine that belongs to the class of tyrosine kinase inhibitors and are primarily used in certain types of cancer treatment.
Here are the key details:
-
Main Use: Prescribed for the treatment of HER2-positive breast cancer, often in patients whose cancer has progressed after other therapies. It may be used alone or in combination with other anticancer medicines.
-
How It Works: Lapatinib blocks the activity of certain proteins (tyrosine kinases) involved in the growth and spread of cancer cells, slowing tumor progression.
-
Administration: Taken orally, usually once daily on an empty stomach or as instructed by the doctor. The dosage depends on the type of cancer and individual patient factors.
-
Common Side Effects: Diarrhea, nausea, vomiting, rash, fatigue, headache, and mild liver enzyme changes.
-
Serious Concerns: May rarely cause heart problems, severe liver toxicity, severe diarrhea leading to dehydration, or lung complications. Regular monitoring by a doctor is required.
-
Precautions:
-
Not recommended in patients with pre-existing heart conditions unless monitored carefully.
-
Liver function tests are usually checked regularly during treatment.
-
Avoid taking other medications or supplements that may interact without doctor guidance.
-
-
Storage: Store at room temperature, away from moisture, heat, and direct sunlight.